This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

BiOasis Poster Being Presented At 17th Annual Blood-Brain Barrier Consortium Meeting

Stocks in this article: BTI

VANCOUVER, British Columbia, March 24, 2011 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) announces it is presenting Friday, March 25, 2011 a poster titled "A new Carrier for Delivery of Therapeutic Compounds Across the BBB for the Treatment of Brain Diseases" at the 17 th annual Blood-Brain Barrier Consortium meeting held in collaboration with the International Brain Barriers Society (IBBS) being held in Stevenson, Washington.

The poster provides a summary of key scientific accomplishments achieved by the Company, including results from its recent collaborations with the University of British Columbia and the National Research Council of Canada. The data from these collaborations further demonstrated that conjugations developed under the biOasis Transcend program cross the blood-brain barrier more efficiently than is possible with other approaches, that the conjugates enter the brain tissue, and that a conjugate incorporating doxorubicin increased survival time in animal models of glioblastoma, the most common and most aggressive type of primary brain tumor in humans. A copy of the poster can be downloaded from our web site at www.bioasis.ca

"We are pleased to participate in this meeting, both as a corporate sponsor and by presenting a poster," stated Dr. Reinhard Gabathuler. "The IBBS meeting provides the opportunity to share and discuss our findings with thought leaders in the blood-brain barrier research community."

The IBBS is an international scientific and educational nonprofit organization that: encourages, promotes and advocates scientific and clinical research on the biological barriers in the central nervous system (CNS); accumulates information about barriers in the CNS and promotes its dissemination to scientists, physicians, patients, policy makers, public and private funding agencies and other concerned parties, and; educates the general public and medical profession about the existence, diagnosis and treatment of disorders involving the barriers of the CNS.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,837.23 +27.17 0.15%
S&P 500 2,068.34 +4.84 0.23%
NASDAQ 4,739.4120 +26.4420 0.56%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs